New Seed Grant Program Tackles Societal Challenges With Broad-Based Research Teams
The new Knowledge and Innovation Program (KIP) of the Rensselaer Office of Research has awarded four grants to spur multidisciplinary research.
RPI Announces $10 Million Gift from Alumnus and Entrepreneur Ajit Prabhu
Rensselaer Polytechnic Institute (RPI) has received a $10 million gift from Ajit Prabhu ’98, founder and CEO of Quest Global, to establish the Ajit Prabhu Catalyst Endowment and the Ajit Prabhu Catalyst Fund, both in support of the Office of Strategic Alliances and Translation (OSAT). Prabhu launched the fund, which will assist RPI student and faculty entrepreneurs.
RPI and Rensselaer County Join in Historic Partnership to Launch a New Entrepreneurship and Innovation Business Accelerator in Downtown Troy
Rensselaer Polytechnic Institute (RPI) and Rensselaer County are teaming up to launch a revolutionary business accelerator in downtown Troy to encourage investment, invention and entrepreneurship, RPI President Martin A. Schmidt ’81 Ph.D. and County Executive Steven F. McLaughlin announced today.
Professor Jonathan Dordick Receives Two Prestigious Honors
Jonathan Dordick, Ph.D., Vice President for Strategic Alliances and Translation and Institute Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute (RPI), has recently received two prestigious honors.
Scientists’ Discovery Could Reduce Dependence on Animals for Vital Anti-Blood Clot Drug
Heparin, the world’s most widely used blood thinner, is used during procedures ranging from kidney dialysis to open heart surgery. Currently, heparin is derived from pig intestines, but scientists at Rensselaer Polytechnic Institute have discovered how to make it in the lab. They have also developed a path to a biomanufacturing process that could potentially revolutionize how the world gets its supply of this crucial medicine.
Rensselaer Professor Jonathan Dordick and Collaborators Work To Develop Nasal Spray To Combat COVID-19 and Other Respiratory Infections
Rensselaer Professor Jonathan Dordick and collaborators from Rensselaer Polytechnic Institute and Albany Medical College have been awarded $500,000 from the New York State Biodefense Commercialization Fund to engage in research for the development of a Pentosan Polysulfate (PPS)-based nasal spray to block COVID-19.
Rensselaer-Designed Platform Could Enable Personalized Immunotherapy
An innovative testing platform that more closely mimics what cancer encounters in the body may allow for more precise, personalized therapies by enabling the rapid study of multiple therapeutic combinations against tumor cells. The platform, which uses a three-dimensional environment to more closely mirror a tumor microenvironment, is demonstrated in research published in Communications Biology.
Common Bacteria Modified To Make Designer Sugar-Based Drug
Envisioning an animal-free drug supply, scientists have — for the first time — reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals.
Jonathan Dordick Elected to National Academy of Engineering
TROY, N.Y. — Jonathan Dordick, the Howard P. Isermann ’42 Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, has been elected to the National Academy of Engineering (NAE), for his “contributions to methods for rapidly screening drug efficacy and toxicity, and biocatalytic technologies for improving human health.”